Cytophage Technologies Ltd. (TSE:CYTO)
TSXV:CYTO
Canadian Market

Cytophage Technologies Ltd. (CYTO) Financial Statements

2 Followers

Cytophage Technologies Ltd. Financial Overview

Cytophage Technologies Ltd.'s market cap is currently ―. The company's EPS TTM is C$; its P/E ratio is ―; Cytophage Technologies Ltd. is scheduled to report earnings on May 30, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -4.26MC$ 911.61KC$ 29.41KC$ 43.97KC$ 40.70K
EBITDAC$ -4.08MC$ 911.61KC$ 29.41KC$ 43.97KC$ 40.70K
Net Income Common StockholdersC$ -4.28MC$ 912.28KC$ 29.41KC$ 43.97KC$ 40.70K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 5.57MC$ 5.43MC$ 5.54MC$ 5.50MC$ 5.46M
Total AssetsC$ 8.74MC$ 5.46MC$ 5.54MC$ 5.50MC$ 5.46M
Total DebtC$ 1.71MC$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -3.85MC$ -5.43MC$ -5.54MC$ -5.50MC$ -5.46M
Total LiabilitiesC$ 2.24MC$ 49.45KC$ 38.30KC$ 25.39KC$ 33.82K
Stockholders EquityC$ 6.50MC$ 5.41MC$ 5.50MC$ 5.47MC$ 5.43M
Cash Flow-
Free Cash Flow-C$ -320.65KC$ 148.44KC$ -22.99KC$ -18.00
Operating Cash FlowC$ -2.11MC$ -320.65KC$ 148.44KC$ -22.99KC$ -18.00
Investing Cash FlowC$ 7.79MC$ 299.88KC$ -168.85K--
Financing Cash FlowC$ -142.37K----
Currency in CAD

Cytophage Technologies Ltd. Earnings and Revenue History

Cytophage Technologies Ltd. Debt to Assets

Cytophage Technologies Ltd. Cash Flow

Cytophage Technologies Ltd. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis